Mikrochirurgische Endodontologie. Bertrand Khayat
immunosuppression. Environ Health Perspect 1982;43:9–19.
2.Guggenheimer J, Eghtesad B, Stock DJ. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:383–389.
3.Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017.
4.Campo J, et al. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients. Oral Dis 2007;13:110–116.
5.Moswin AH, Epstein JB. Essential medical issues related to HIV in dentistry. J Can Dent Assoc 2007;73(10):945–948.
6.Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Car 1999;22:1408–1414.
7.Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr 2002;49(5):531–537.
8.Goëb V, et al. Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health. Joint Bone Spine 2013;80(6):574–580.
9.Scottish Dental Clinical Effectiveness Programme (SDCEP) 2015. Management of dental patients taking anticoagulants or antiplatelet drugs. Dental Clinical Guidance. Available from: http://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf
10.Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G. Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol 2011;108(7):964–967.
11.Peterson P, Hayest E, Arkin CF, Bovill EG, Fairweather RB, Rock WA Jr, Triplett DA, Brandt J. The preoperative bleeding time test lacks clinical benefit. Arch Surg 1998;133(2):134–139.
12.Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis altering medication. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:S45.e1–11.
13.Favaloro EJ, Lippi G. The new oral anticoagulants and the future of haemostasis laboratory testing. Biochem Med (Zagreb) 2012;22:329–341.
14.Saad F, Brown JE, Van Poznak C, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 2012;23:1341.
15.American Association of Oral and Maxillofacial Surgeons. Medication-Related Osteonecrosis of the Jaw-2014 Update. 2014.
16.Lo JC, O’Ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010;68(2):243.
17.Damm DD, Jones DM. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays. Gen Dent 2013;61:33.
18.WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization, 2009.
19.Jin GC, Kim KD, Roh BD, Lee CY, Lee SJ. Buccal Bone Plate Thickness of the Asian People. J Endod 2005;31(6):430–434.
20.Agbaje JO, Van de Casteele E, Hiel M, Verbaanderd C, Lambrichts I, Politis C. Neuropathy of trigeminal nerve branches after oral and maxillofacial treatment. J Maxillofac Oral Surg 2016;15:321–327.
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.